ICU Medical (ICUI) Tops Q2 EPS by 10c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119
August 9, 2016 8:38 AM EDTPiper Jaffray reiterated a Neutral rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $119.00 (from $115.00), following the company's 2Q earnings report. ICUI reported revenues of $96.7M, ahead of the consensus of $89.9M. Adjusted EPS of $1.15 also outperformed expectations, compared to $1.05 consensus.... More
